DMAC
DiaMedica Therapeutics Inc.
Latest Form 4:Purchase$1.2MbySTAHLBERG JAN (10% Owner) · filed Dec 8, 2025
DiaMedica Therapeutics Inc. (DMAC) has 6 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 12, 2026.
The most active filer is 10% Owner STAHLBERG JAN with 7 filings.
- Industry:Biotechnology
- CEO:Dietrich John Pauls
- Employees:35
- HQ:Minneapolis, MN, US
- IPO:2012-08-03
Insider Buying
$7.6M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$364.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
STAHLBERG JANFirst filing | 10% Owner | Purchase | 187,393 | $1.2M | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 182,882 | $1.2M | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 240,352 | $1.7M | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 128,426 | $951K | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 208,872 | $1.5M | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 40,253 | $318K | Dec 8 | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 73,099 | $627K | Dec 8 | SEC ↗ |
Related companies
DiaMedica Therapeutics Inc. is in the Healthcare sector.